KLRK1 and neoplasm: After soluble ligands bind to NKG2D, they induce the internalization or degradation of NKG2D receptors on the surface of NK cells and CD8+ T cells, inhibiting the cytotoxicity of these immune cells and thereby mediating tumor immune escape [35,36].